Zyactin Tablet is a medicine brand authorised in South Africa. This page provides limited product identification information only .
Medicine name : Zyactin Tablet
Country: South Africa
Schedule: S2
Active ingredients :
| Category | Ingredient / Claim | Per tablet |
|---|---|---|
| Active ingredient | Cyproheptadine | As hydrochloride |
| Sugar content | Lactose monohydrate | 40 mg |
| Other ingredient | Details |
|---|---|
| Magnesium stearate | E572 |
| Microcrystalline cellulose | E460(i) |
| Sodium starch glycolate | — |
If You have been Legally Prescribed : Click Here
Zyactin Tablet is a scheduled medicine in South Africa. Detailed information, including its uses, warnings, precautions, dosage guidance and possible side effects, is intended only for registered healthcare professionals or for patients to whom the medicine has been legally prescribed.
This page does not provide medical advice, treatment recommendations, promotional claims, or instructions for use. Please consult a registered doctor, pharmacist, or other qualified healthcare professional for information specific to your condition and prescription.
For your safety, do not use Zyactin Tablet unless it has been prescribed or supplied to you in accordance with South African medicine regulations.
Manufacturer/holder
Zydus Healthcare SA (Pty) Ltd
SAHPRA / product identifier : 55/5.7.1/0847
Sources
Written by: RxZest Editorial Team
Editorial review: Checked for readability, structure, and source alignment
Based on SAHPRA-approved information : Zyactin Tablet
Last updated: [09/05/2026]
